Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India.

Chakraborty A, Bose CK, Basak J, Sen AN, Mishra R, Mukhopadhyay A.

Indian J Med Res. 2016 May;143(Supplement):S45-S51. doi: 10.4103/0971-5916.191761.

2.

Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.

Orucevic A, Chen J, McLoughlin JM, Heidel RE, Panella T, Bell J.

Breast J. 2015 Mar-Apr;21(2):147-54. doi: 10.1111/tbj.12367. Epub 2015 Jan 20.

PMID:
25600504
3.

Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology.

Jung HA, Park YH, Kim M, Kim S, Chang WJ, Choi MK, Hong JY, Kim SW, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.

Tumour Biol. 2015 Feb;36(2):1073-9. doi: 10.1007/s13277-014-2730-2. Epub 2014 Oct 19.

PMID:
25326808
4.

[Breast cancer classification is evolving].

Penault-Llorca F.

Biol Aujourdhui. 2014;208(4):251-9. doi: 10.1051/jbio/2014028. Epub 2015 Apr 3. Review. French.

PMID:
25840451
5.

Personalizing breast cancer staging by the inclusion of ER, PR, and HER2.

Bagaria SP, Ray PS, Sim MS, Ye X, Shamonki JM, Cui X, Giuliano AE.

JAMA Surg. 2014 Feb;149(2):125-9. doi: 10.1001/jamasurg.2013.3181.

PMID:
24306257
6.

The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.

Hofmann G, Balic M, Dandachi N, Resel M, Schippinger W, Regitnig P, Samonigg H, Bauernhofer T.

Clin Biochem. 2013 Oct;46(15):1585-9. doi: 10.1016/j.clinbiochem.2013.06.010. Epub 2013 Jun 18.

PMID:
23792261
7.

Clinical profile of patients presenting with breast cancer in Nepal.

Acharya SC, Jha AK, Manandhar T.

Kathmandu Univ Med J (KUMJ). 2012 Jul-Sep;10(39):3-7.

PMID:
23434953
8.

Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.

Duman BB, Afşar ÇU, Günaldi M, Sahin B, Kara IO, Erkisi M, Erçolak V.

Asian Pac J Cancer Prev. 2012;13(8):4119-23.

9.

Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.

Cao AY, He M, Liu ZB, Di GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM.

Ann Surg Oncol. 2012 Sep;19(9):3019-27. doi: 10.1245/s10434-012-2322-6. Epub 2012 Mar 27.

PMID:
22451233
10.

Clinical relevance of TNM staging system according to breast cancer subtypes.

Park YH, Lee SJ, Cho EY, Choi YL, Lee JE, Nam SJ, Yang JH, Shin JH, Ko EY, Han BK, Ahn JS, Im YH.

Ann Oncol. 2011 Jul;22(7):1554-60. doi: 10.1093/annonc/mdq617. Epub 2011 Jan 17.

PMID:
21242587
12.

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia R, Catalano G, Galimberti V, Nolé F, Martinelli G, Goldhirsch A.

Ann Oncol. 2002 Feb;13(2):273-9.

PMID:
11886005

Supplemental Content

Loading ...
Support Center